Li Hw, Zhang Hh. The Protein Acetylation after Traumatic Spinal Cord Injury: Mechanisms and Therapeutic Opportunities. Int J Med Sci 2024; 21(4):725-731. doi:10.7150/ijms.92222. https://www.medsci.org/v21p0725.htm
Spinal cord injury (SCI) leads to deficits of various normal functions and is difficult to return to a normal state. Histone and non-histone protein acetylation after SCI is well documented and regulates spinal cord plasticity, axonal growth, and sensory axon regeneration. However, our understanding of protein acetylation after SCI is still limited. In this review, we summarize current research on the role of acetylation of histone and non-histone proteins in regulating neuron growth and axonal regeneration in SCI. Furthermore, we discuss inhibitors and activators targeting acetylation-related enzymes, such as α-tubulin acetyltransferase 1 (αTAT1), histone deacetylase 6 (HDAC6), and sirtuin 2 (SIRT2), to provide promising opportunities for recovery from SCI. In conclusion, a comprehensive understanding of protein acetylation and deacetylation in SCI may contribute to the development of SCI treatment.
Keywords: spinal cord injury, protein acetylation, HAT, HDAC, inhibitors
Citation styles
APA
Li, H.w., Zhang, H.h. (2024). The Protein Acetylation after Traumatic Spinal Cord Injury: Mechanisms and Therapeutic Opportunities. International Journal of Medical Sciences, 21(4), 725-731. https://doi.org/10.7150/ijms.92222.
ACS
Li, H.w.; Zhang, H.h. The Protein Acetylation after Traumatic Spinal Cord Injury: Mechanisms and Therapeutic Opportunities. Int. J. Med. Sci. 2024, 21 (4), 725-731. DOI: 10.7150/ijms.92222.
NLM
Li Hw, Zhang Hh. The Protein Acetylation after Traumatic Spinal Cord Injury: Mechanisms and Therapeutic Opportunities. Int J Med Sci 2024; 21(4):725-731. doi:10.7150/ijms.92222. https://www.medsci.org/v21p0725.htm
CSE
Li Hw, Zhang Hh. 2024. The Protein Acetylation after Traumatic Spinal Cord Injury: Mechanisms and Therapeutic Opportunities. Int J Med Sci. 21(4):725-731.
This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.